Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer

• Autore principale: Van Laar Ryan K (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2012-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Improved methods are needed for predicting prognosis and the benefit of delivering adjuvant chemotherapy (ACT) in patients with non-small-cell lung cancer (NSCLC).</p> <p>Methods</p> <p>A novel prognostic algo...